Atezolizumab with chemoradiation is safe and demonstrates signs of immune activation in women with cervical cancer
A Phase I/Ib trial conducted by the National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group NRG Oncology, NRG-GY017, concluded that the addition of the immunotherapy drug atezolizumab prior to and concurrently ...
Mar 21, 2022
0
2